Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.

Kirito K, Sugimoto Y, Gotoh A, Takenaka K, Ichii M, Inano T, Shirane S, Ito M, Zagrijtschuk O, Qin A, Kawase H, Sato T, Komatsu N, Shimoda K.

Open source

DOI
10.1007/s12185-024-03846-5
Published
2024-10-03
Container
Int J Hematol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12185-024-03846-5,
  title = {Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.},
  author = {Kirito K and  Sugimoto Y and  Gotoh A and  Takenaka K and  Ichii M and  Inano T and  Shirane S and  Ito M and  Zagrijtschuk O and  Qin A and  Kawase H and  Sato T and  Komatsu N and  Shimoda K.},
  year = {2024},
  journal = {Int J Hematol},
  doi = {10.1007/s12185-024-03846-5},
  url = {https://doi.org/10.1007/s12185-024-03846-5}
}

RIS

TY  - JOUR
TI  - Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.
AU  - Kirito K
AU  -  Sugimoto Y
AU  -  Gotoh A
AU  -  Takenaka K
AU  -  Ichii M
AU  -  Inano T
AU  -  Shirane S
AU  -  Ito M
AU  -  Zagrijtschuk O
AU  -  Qin A
AU  -  Kawase H
AU  -  Sato T
AU  -  Komatsu N
AU  -  Shimoda K.
PY  - 2024
JO  - Int J Hematol
DO  - 10.1007/s12185-024-03846-5
UR  - https://doi.org/10.1007/s12185-024-03846-5
ER  - 

APA

K, K., Y, S., A, G., K, T., M, I., T, I., S, S., M, I., O, Z., A, Q., H, K., T, S., N, K., & K., S. (2024). Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.. Int J Hematol. https://doi.org/10.1007/s12185-024-03846-5

Source records